Analysis of blood chemistries at 48 hours after infection of the CD11c Cre+Ifnarf/f and Ifnar−/− mice following anti-TNF-α treatment revealed improved AST, ALT, and glucose levels that were not different from WNV-infected Cre−Ifnarf/f control mice (Fig. 7C and Table 3). The gene discussed is ITGAX; the disease is infection.